imatinib mesylate has been researched along with Adrenal Cancer in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abou Al-Shaar, H; Abu-Zaid, A; Amin, T; Azzam, A; Solimanie, S | 1 |
Bobrzyk, M; Chronowska, J; Kukla, U; Madej, P; Okopień, B; Łabuzek, K | 1 |
De Arriba, JJ; García, E; Gómez-Aldaraví, L; Nerín, C; Vila, B | 1 |
3 other study(ies) available for imatinib mesylate and Adrenal Cancer
Article | Year |
---|---|
Gastrointestinal stromal tumor of the adrenal gland:a case report and review of the literature.
Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Biopsy; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Piperazines; Positron-Emission Tomography; Pyrimidines | 2015 |
[Antiangiogenic therapy of malignant pheochromocytoma and paraganglioma with the view to the recent scientific developments].
Topics: Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Benzamides; Humans; Imatinib Mesylate; Indoles; Neovascularization, Pathologic; Paraganglioma; Pheochromocytoma; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Sunitinib; Thalidomide | 2015 |
Severe hemolytic anemia and skin reaction in a patient treated with imatinib.
Topics: Adrenal Gland Neoplasms; Anemia, Hemolytic; Antineoplastic Agents; Benzamides; Exanthema; Female; Humans; Imatinib Mesylate; Liver Neoplasms; Middle Aged; Piperazines; Pyrimidines; Risk Factors; Splenic Neoplasms; Stomach Neoplasms | 2003 |